XYL
49
4
WU
32
2
HPE
63
2
HST
49
-9
RHI
59
2
FLR
58
3
INTC
33
-2
ORLY
62
2
BA
54
5
PRGO
39
3
HOG
35
2
MCD
52
2
LLY
37
-3
CF
57
-2
A
43
2
MPC
44
-3
TROW
56
5
BWA
48
2
CMG
72
5
BSX
67
-3
XYL
49
4
WU
32
2
HPE
63
2
HST
49
-9
RHI
59
2
FLR
58
3
INTC
33
-2
ORLY
62
2
BA
54
5
PRGO
39
3
HOG
35
2
MCD
52
2
LLY
37
-3
CF
57
-2
A
43
2
MPC
44
-3
TROW
56
5
BWA
48
2
CMG
72
5
BSX
67
-3
Financhill
Back

Haemonetics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
72

HAE
Haemonetics

Last Price:
85.59
Seasonality Move:
0.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Haemonetics Price Quote

$85.59
+0.04 (+0.19%)
(Updated: November 23, 2024 at 5:38 AM ET)

Haemonetics Key Stats

Buy
72
Haemonetics (HAE) is a Buy
Day range:
$84.50 - $86.00
52-week range:
$70.25 - $97.97
Dividend yield:
0%
P/E ratio:
37.36
P/S ratio:
3.23
P/B ratio:
4.89%
Volume:
481K
Avg. volume:
653.7K
1-year change:
4.35%
Market cap:
$4.3B
Revenue:
$1.3B
EPS:
$2.41

How Much Does Haemonetics Make?

  • How Much Are Haemonetics's Sales Annually?
    HAE Revenues are $1.3B
  • How Much Profit Does Haemonetics's Make A Year?
    HAE net income is $117.6M

Is Haemonetics Growing As A Company?

  • What Is Haemonetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.09%
  • What Is Haemonetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.38%

Haemonetics Stock Price Performance

  • Did Haemonetics Stock Go Up Last Month?
    Haemonetics share price went up by 14.88% last month
  • Did HAE's Share Price Rise Over The Last Year?
    HAE share price rose by 4.35% over the past 1 year

What Is Haemonetics 52-Week High & Low?

  • What Is Haemonetics’s 52-Week High Share Price?
    Haemonetics has traded as high as $97.97 over the past 52 weeks
  • What Is Haemonetics’s 52-Week Low Share Price?
    Haemonetics has traded as low as $70.25 over the past 52 weeks

Haemonetics Price To Free Cash Flow

Is It Risky To Buy Haemonetics?

  • How Much Debt Does Haemonetics Have?
    Total long term debt quarterly is $1.2B
  • How Much Cash Does Haemonetics Have?
    Cash and short term investments quarterly total is $299.3M
  • What Is Haemonetics’s Book Value Per Share?
    Book value per share is 17.44

Is Haemonetics Cash Flow Positive?

  • What Is HAE Cash Flow From Operations?
    Cash flow from operations (TTM) is $84.9M
  • What Is Haemonetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $304.8M
  • What Is Haemonetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$444.6M

Haemonetics Return On Invested Capital

  • Is Management Doing A Good Job?
    HAE return on invested capital is 6.54%
  • What Is Haemonetics Return On Assets?
    ROA measures how assets are converting to revenues and is 5.4%
  • What Is HAE Return On Equity?
    ROE is a measure of profitability and is 13.51%

Haemonetics Earnings Date & Stock Price

  • What Is Haemonetics's Stock Price Today?
    A single share of HAE can be purchased today for 85.55
  • What Is Haemonetics’s Stock Symbol?
    Haemonetics trades on the nyse under the ticker symbol: HAE
  • When Is Haemonetics’s Next Earnings Date?
    The next quarterly earnings date for Haemonetics is scheduled on February 7, 2025
  • When Is HAE's next ex-dividend date?
    Haemonetics's next ex-dividend date is November 24, 2024
  • How To Buy Haemonetics Stock?
    You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Haemonetics Competitors

  • Who Are Haemonetics's Competitors?
    Below is a list of companies who compete with Haemonetics or are related in some way:
    • Baxter International Inc (BAX)
    • Boston Scientific Corp (BSX)
    • Globus Medical Inc (GMED)
    • Integra Lifesciences Holdings Corp (IART)
    • ResMed Inc (RMD)

Haemonetics Dividend Yield

Haemonetics Analyst Estimates

YoY Growth Past Surprise
EPS: 37.5% 4.39%
Revenue: 8.59% 0.86%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 110.80
Upside from Last Price: 29.51%

Major Shareholders

  • How many HAE shares are owned by institutional investors?
    94.2M HAE shares are owned by institutional investors
  • How many HAE shares are owned by insiders?
    1.4M HAE shares are owned by insiders